| 1 | 97202-63-6 | | 2(3H)-Indolizinone, 5,6,7,8-tetrahydro- | C8H11NO | | |
| 2 | 97203-04-8 | 7-Dehydroxy Buprenorphine(Buprenorphine IMpurity F) | 7-Dehydroxy Buprenorphine(Buprenorphine IMpurity F) | C29H39NO3 | | |
| 3 | 97204-18-7 | | 2-Pentenal, 5-(5-methyl-2-furanyl)-, (E)- (9CI) | C10H12O2 | | |
| 4 | 97204-34-7 | 3-Hexene-2,5-dione, 3-methyl-, (3Z)- (9CI) | 3-Hexene-2,5-dione, 3-methyl-, (3Z)- (9CI) | C7H10O2 | | |
| 5 | 97204-62-1 | | Octanenitrile, 6-methyl- | C9H17N | | |
| 6 | 97204-87-0 | | Thymidine, 3',5'-O-[bis(1,1-dimethylethyl)silylene]- | C18H30N2O5Si | | |
| 7 | 97205-08-8 | Methyl2,3,4,6-tetra-O-benzyl-a-D-thiogalactopyranoside | Methyl2,3,4,6-tetra-O-benzyl-a-D-thiogalactopyranoside | C35H38O5S | | |
| 8 | 97205-34-0 | 4-(氨甲基)-1-苄基吡咯烷-2-酮 | nebracetam | C12H16N2O | | |
| 9 | 97205-35-1 | 4-(aminomethyl)-1-benzyl-pyrrolidin-2-one | 4-(aminomethyl)-1-benzyl-pyrrolidin-2-one | C12H16N2O | | |
| 10 | 97205-51-1 | 1-HYDROXYETHYL-5-HYDROXY-1H-PYRAZOLO[3,4-B]PYRAZINE | 1-Hydroxyethyl-5-hydroxy-1H-pyrazolo[3,4-b]pyrazine | C7H8N4O2 | | |
| 11 | 97206-21-8 | | (2R)-2-{[(benzyloxy)carbonyl]amino}-2-methyl-3-phenylpropanoic acid | C18H19NO4 | | |
| 12 | 97206-75-2 | 1-Phenylamino-2-hexanol | 1-Phenylamino-2-hexanol | C12H19NO | | |
| 13 | 97207-23-3 | 2',3'-DIMETHOXYFLAVANONE | 2',3'-DIMETHOXYFLAVANONE | C17H14O4 | | |
| 14 | 97207-35-7 | tert-butyloxycarbonyl-phenylalanyl-phenylalanyl-glycine hydroxylamine | tert-butyloxycarbonyl-phenylalanyl-phenylalanyl-glycine hydroxylamine | C25H32N4O6 | | |
| 15 | 97207-36-8 | 3-iododesaminotyrosyl-phenylalanyl-phenylalanyl-glycine hydroxamic acid | 3-iododesaminotyrosyl-phenylalanyl-phenylalanyl-glycine hydroxamic acid | C29H31IN4O6 | | |
| 16 | 97207-37-9 | substance P (6-11), N(alpha)-(3-iododesaminotyrosyl)- | substance P (6-11), N(alpha)-(3-iododesaminotyrosyl)- | C45H59IN8O9S | | |
| 17 | 97207-45-9 | [(5-METHYL-FURAN-2-CARBONYL)-AMINO]-ACETIC ACID | [(5-METHYL-FURAN-2-CARBONYL)-AMINO]-ACETIC ACID | C8H9NO4 | | |
| 18 | 97207-47-1 | Meisoindigo | Meisoindigo | C17H12N2O2 | 标准品;中药对照品;小分子抑制剂;医药化工中间体;小分子抑制剂，天然产物 | |
| 19 | 97208-92-9 | 2-Octene-4,6-diynamide, 2-methoxy- | 2-Octene-4,6-diynamide, 2-methoxy- | C9H9NO2 | | |
| 20 | 97209-05-7 | 4-CHLORO-3-ETHOXYBENZOIC ACID | 4-CHLORO-3-ETHOXYBENZOIC ACID | C9H9ClO3 | | |
| 21 | 97209-67-1 | | L-Valinamide, 1-[[(2-chloroethyl)nitrosoamino]carbonyl]-L-prolyl- (9CI) | C13H22ClN5O4 | | |
| 22 | 97209-92-2 | | Benzoic acid, 3,4,5-tris(acetyloxy)-, 4-[(1-oxohexadecyl)oxy]butyl ester | C33H50O10 | | |
| 23 | 97209-93-3 | | Benzoic acid, 3,4,5-trimethoxy-, 1,1'-(1,2-ethanediyl) ester | C22H26O10 | | |
| 24 | 97209-94-4 | | Benzoic acid, 3,4,5-trimethoxy-, 1,4-butanediyl ester (9CI) | C24H30O10 | | |
| 25 | 97209-96-6 | | 2-Butanol, 4-(decyloxy)- | C14H30O2 | | |
| 26 | 97209-97-7 | 4-(癸氧基)-正丁醇 | MFCD01656200 | C14H30O2 | | |